UpdatesPress Release
Mankind Pharma signed an exclusive in-licensing deal with Chongqing Chenan Biopharmaceutical for two insulin analogues in India.
Mankind Pharma LimitedMANKIND · Filed with the exchange
This strengthens its diabetes segment presence and expands its injectable diabetes portfolio.
No comments yet. Be the first.